Insider Transactions in Q2 2025 at Nutex Health, Inc. (NUTX)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Apr 08
2025
|
Jon Christian Bates Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+16.98%
|
$81,000
$81.81 P/Share
|
Apr 04
2025
|
Kelvin Spears Director |
SELL
Payment of exercise price or tax liability
|
Direct |
34
-0.11%
|
$2,448
$72.1 P/Share
|
Apr 04
2025
|
Joshua De Tillio Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
452
-6.52%
|
$32,544
$72.1 P/Share
|
Apr 04
2025
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
290
-11.04%
|
$20,880
$72.1 P/Share
|
Apr 04
2025
|
Michael L. Chang Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
266
-0.33%
|
$19,152
$72.1 P/Share
|
Apr 04
2025
|
Thomas T. Vo Chief Executive Officer |
BUY
Payment of exercise price or tax liability
|
Indirect |
895
+0.05%
|
$64,440
$72.1 P/Share
|
Apr 04
2025
|
Warren Hosseinion President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,072
-23.85%
|
$77,184
$72.1 P/Share
|
Apr 04
2025
|
Elisa V Luqman Chief Legal Officer - SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
266
-19.91%
|
$19,152
$72.1 P/Share
|